Anatomic site of infection | Control arm | EPT arm | ||
---|---|---|---|---|
Baseline (N = 84)a | Follow-up (N = 72) | Baseline (N = 89) | Follow-up (N = 83) | |
Any site/any pathogen | n = 79b 94.0% (86.8–97.4%) | n = 2c 2.8% (0.8–9.6%) | n = 81 91.0% (83.2–95.4%) | n = 2 2.4% (0.7–8.4%) |
Urethral CT | n = 4 5.1% (2.0–12.3%) |  | n = 10 11.2% (6.2–19.5%) |  |
Urethral GC | n = 6 7.1% (3.3–14.7%) |  | n = 11 12.4% (7.0–20.8%) |  |
Urethral CT and GC | n = 2 2.4% (0.6–8.3%) |  | n = 5 6.2% (2.7–13.6%) |  |
Rectal CT | n = 24 28.6% (20.0–39.0%) | n = 2 2.8% (0.8–9.6%) | n = 32 36.0% (26.8–46.3%) | n = 1 1.2% (0.2–6.5%) |
Rectal GC | n = 12 14.3% (8.4–23.3%) |  | n = 4 4.5% (1.8–11.0%) |  |
Rectal CT and GC | n = 9 10.7% (5.7–19.1%) |  | n = 5 6.2% (2.7–13.6%) |  |
Pharyngeal CT | n = 8 9.5% (4.9–17.7%) |  | n = 1 7.9% (3.9–15.4%) |  |
Pharyngeal GC | n = 15 17.9% (11.1–27.4%) |  | n = 21 25.9% (17.6–36.4%) | n = 1 1.2% (0.2–6.5%) |
Pharyngeal CT and GC | n = 1 1.2% (0.2–7.4%) |  | n = 1 1.2% (0.2–6.7%) |  |